Cointime

Gossamer Bio

company

About

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

  • 101 - 250

Highlights

Total Funding Amount
$330M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Series A
Last Funding Money Raised
$100M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
101 - 250
Operating Status
Active

Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$330M
Gossamer Bio has raised a total of $330M in funding over 2 rounds. Their latest funding was raised on Jul 23, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 23, 2018 Series B $230M 2 — — Detail
Jan 4, 2018 Series A $100M 1 ARCH Venture Partners — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Gossamer Bio is funded by 2 investors. ARCH Venture Partners and Abu Dhabi Investment Authority are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners — Series B
Abu Dhabi Investment Authority — Series B
Cointime
Chủ Đề
Công Ty